Sign Up to like & get
recommendations!
0
Published in 2017 at "International Journal of Trichology"
DOI: 10.4103/ijt.ijt_1_17
Abstract: Tyrosine kinase enzymes are an attractive target for anticancer therapies. Tyrosine kinase inhibitors (TKI) are well tolerated; somehow severe systemic side effects are rarely seen during treatment. Toxicities of skin and appendages may lead to…
read more here.
Keywords:
alopecia areata;
nilotinib induced;
associated alopecia;
keratosis pilaris ... See more keywords